J9000 Doxorubicin hcl injection
Also known as: Adriamycin, Doxorubicin, DOX
Doxorubicin hydrochloride administered by injection; an anthracycline chemotherapy drug used for various malignancies.
In Plain Language
Cancer chemotherapy injection; Red chemotherapy drug
Clinical Context
Used for breast cancer, lymphoma, leukemia, and sarcomas. Intercalates DNA and generates free radicals. Cardiotoxicity is a major side effect.
RVU Information
CPT J9000 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.
Specialties
Frequently Asked Questions
What is CPT code J9000?
CPT J9000 (Doxorubicin hcl injection) is a J Codes (Drugs) code. Doxorubicin hydrochloride administered by injection; an anthracycline chemotherapy drug used for various malignancies.
How is J9000 administered?
CPT J9000 is administered by a healthcare provider, typically via injection or infusion. Used for breast cancer, lymphoma, leukemia, and sarcomas. Intercalates DNA and generates free radicals. Cardiotoxicity is a major side effect. It is used by Oncology, Cardio-Oncology, Internal Medicine.
When is CPT J9000 used?
Used for breast cancer, lymphoma, leukemia, and sarcomas. Intercalates DNA and generates free radicals. Cardiotoxicity is a major side effect.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.